Zhang Junge 4

What Happened

• Zhang Junge, a director of Ocugen, Inc. (OCGN), received a derivative equity award on June 11, 2026 covering 170,100 shares. The filing reports an acquisition at $0.00 (no cash paid at grant). The award is reported as a grant/award (Form 4 code A), not a sale.

Key Details

• Transaction date: 2026-06-11; Form 4 filed: 2026-06-15 (timely).
• Security: Derivative award (option) for 170,100 shares; reported price/exercise listed as $0.00.
• Shares owned after transaction: Not specified in the excerpt provided.
• Vesting (footnote F1): The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen’s next annual meeting of stockholders, subject to the reporting person’s continued service through the applicable vesting date.
• Transaction code: A = Award/Grant (derivative).

Context

• This report reflects a compensatory option grant to a director; no shares were sold or bought on the open market and there was no immediate cash outlay. The options vest in the future and require continued service before they become exercisable, so they are not immediately liquid. As with other grants, the filing is informational about insider compensation rather than a direct bullish or bearish market signal.